Collplant Biotechnologies Ltd

Company Profile

Collplant Biotechnologies Ltd had its IPO on 2018-01-30 under the ticker symbol CLGN.

The company operates in the LIFE SCIENCES sector and ORTHOPEDIC industry. Collplant Biotechnologies Ltd has a staff strength of 0 employees.

Stock update

Shares of Collplant Biotechnologies Ltd opened at $6.22 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $6.1 - $7, and closed at $6.29.

This is a +4.66% increase from the previous day's closing price.

A total volume of 40,067 shares were traded at the close of the day’s session.

In the last one week, shares of Collplant Biotechnologies Ltd have increased by +4.83%.

Collplant Biotechnologies Ltd's Key Ratios

Collplant Biotechnologies Ltd has a market cap of $0.070 billion, indicating a price to book ratio of 1.757 and a price to sales ratio of 119.82.

In the last 12-months Collplant Biotechnologies Ltd’s revenue was $0.001 billion with a gross profit of $0.014 billion and an EBITDA of $-0.014 billion. The EBITDA ratio measures Collplant Biotechnologies Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Collplant Biotechnologies Ltd’s operating margin was -2552% while its return on assets stood at -18.7% with a return of equity of -33.7%.

In Q2, Collplant Biotechnologies Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a negative 90.4%.

Collplant Biotechnologies Ltd’s PE and PEG Ratio

Forward PE

4.924

Trailing PE

-

PEG

None

Its diluted EPS in the last 12-months stands at $-1.302 per share while it has a forward price to earnings multiple of 4.924 and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Collplant Biotechnologies Ltd’s profitability.

Collplant Biotechnologies Ltd stock is trading at a EV to sales ratio of 62.09 and a EV to EBITDA ratio of -2.594. Its price to sales ratio in the trailing 12-months stood at 119.82.

Collplant Biotechnologies Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

Collplant Biotechnologies Ltd ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Collplant Biotechnologies Ltd ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Collplant Biotechnologies Ltd’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Collplant Biotechnologies Ltd's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Collplant Biotechnologies Ltd paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$6.29

52-Week High

$23

52-Week Low

$6

Analyst Target Price

$17

Collplant Biotechnologies Ltd stock is currently trading at $6.29 per share. It touched a 52-week high of $23 and a 52-week low of $23. Analysts tracking the stock have a 12-month average target price of $17.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.